Original news and analysis on international IP policy
By William New World Intellectual Property Organization members on Friday recommended to move talks on a proposed broadcasters’ and cablecasters’ treaty back to committee level for further consideration, a day after rejecting a proposal to elevate the issue to formal…
After a one-year hiatus, the World Intellectual Property Organization likely will renew its agenda on patent policy issues in 2008 following members' informal approval Friday of a study on patents to be conducted by the WIPO secretariat in autumn, according to officials.
By Tove Iren S. Gerhardsen NOORDWIJK, THE NETHERLANDS – Participants at a high-level meeting of the Organisation for Economic Cooperation and Development (OECD) meeting here informally agreed on an agenda for what needs to be done in the area of…
Por William New Entre el 11 y el 15 de junio, los miembros de un comité de la Organización Mundial de la Propiedad Intelectual (OMPI) cuya misión es considerar propuestas para el Programa de la OMPI para el Desarrollo redactaron…
By William New World Intellectual Property Organization negotiations for a treaty on rights for broadcasters broke down at the eleventh hour, according to participating government officials. A high-level final treaty negotiation scheduled for November will not take place, they said.…
By William New The United States is proposing a patent fee cut at the World Intellectual Property Organization in light of a sizeable financial surplus at the United Nations organization. The proposal is included in materials for the 25-28 June…
By Tove Iren S. Gerhardsen Concerns that a new treaty on broadcasting being discussed at the World Intellectual Property Organization (WIPO) this week will be unbalanced, providing extra protection rights for broadcasters and further limits to users, was the topic…
By William New World Intellectual Property Organization members are engaged in a critical weeklong meeting that will determine the fate of a proposed WIPO treaty on broadcasters’ rights. At the end of a second slow day, it was unclear which…
By Tove Iren S. Gerhardsen Side-events were held by a non-governmental organisation (NGO), an intergovernmental organisation and the Canadian competition authority last week alongside the negotiations for a Development Agenda at the World Intellectual Property Organization. They focused on implementation…
By Tatum Anderson for Intellectual Property Watch
A debate over how long to give exclusive rights over data submitted by pharmaceutical companies to governments in order to receive approval to sell a drug in their markets is controversial not only in India, but worldwide.
By Tatum Anderson for Intellectual Property Watch
When the Indian government published its report recently on yet another pharmaceutical patent-related issue predicted to split the industry, the Indian newspapers were divided as to whether brand name producers, generics producers or public health advocates had won.
The reason for the confusion is that the report is an exercise in appeasement, said Shamnad Basheer, a law professor at George Washington University Law School, and expert on this latest controversial subject, called data exclusivity, which is the rights drugs producers have over the data used to obtain marketing approval in a country.
By Tatum Anderson for Intellectual Property Watch The latest chapter in the Swiss pharmaceutical company Novartis’ challenge to the Indian intellectual property system begins on 18 June when the Indian Patent and Trademark Appellate Board (IPAB) is scheduled to hold…